Charles K. Dargan - Dec 28, 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Financial Officer
Signature
/s/ John R. Browning, Attorney-in-fact
Stock symbol
BLGO
Transactions as of
Dec 28, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 11:48 AM
Previous filing
Jul 5, 2022
Next filing
Mar 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award $0 +205K +5.36% $0.00 4.03M Dec 28, 2022 Common stock 205K $0.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option previously issued to compensate Reporting Person for services to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price and current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.
F2 Reflects the December 28, 2022, expiration of an option to purchase 410,000 shares.